Last reviewed · How we verify
Urethritis
Approved treatments
- Lignocaine · University of Malaya
- Lignospan Forte · Fresenius Kabi
Lidocaine stabilizes neuronal membrane by inhibiting ionic fluxes required for impulse initiation and conduction. - Lidocain · Bayer
- xylocain · Saint-Joseph University
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Urethritis patent landscape — cliff calendar, originator estates, attackable patents
- Urethritis treatment landscape brief
- Urethritis treatment updates RSS
Frequently asked questions about Urethritis
What drugs treat Urethritis?
Tracked treatments include Lignocaine, Lignospan Forte, Lidocain, xylocain.
What is the treatment for Urethritis?
Standard treatment for Urethritis includes Lignocaine, Lignospan Forte, Lidocain, xylocain. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Urethritis patent cliff · Urethritis CI report
- Treatment: Lignocaine · University of Malaya
- Treatment: Lignospan Forte · Fresenius Kabi
- Treatment: Lidocain · Bayer
- Treatment: xylocain · Saint-Joseph University
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing